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Abstract
Protein N-terminal acetylation is a very common modification, but has during the past decades
received relatively little attention. In order to put this neglected field back on the scientific map, we
have in May 2007 and September 2008 arranged two international NAT symposia in Bergen,
Norway. This supplement contains selected proceedings from these symposia reflecting the
current status of the field, including an overview of protein N-terminal acetylation in yeast and
humans, a novel nomenclature system for the N-terminal acetyltransferases (NATs) and methods
for studying protein N-terminal acetylation in vitro and in vivo.
Introduction
More than 50 years ago, the first N-terminally acetylated
protein was discovered [1]. Since then, numerous proteins
carrying this modification have been reported, and it has
become evident that protein N-terminal acetylation is a
major modification in eukaryotic cells. In the 1970s, work
from Brown indicated that approximately 80% of the sol-
uble proteins from mammalian cells were N-terminally
acetylated [2,3]. In the same period, the basic concepts of
N-terminal acetylation were revealed. Strous and Bloe-
mendal demonstrated that this type of acetylation was a
co-translational phenomenon, occurring on nascent
polypeptide chains. N-terminal acetylation occurred in
an in vitro cell free system, when about 25–50 amino acid
residues protruded from the ribosome [4,5]. In parallel,
Pestana and Pitot presented data supporting the same
model [6,7]. Their results strongly indicated that this reac-
tion was catalyzed by enzyme(s) physically associated to
the ribosomes and furthermore suggested that N-terminal
acetylation occurs on polypeptides 40–70 amino acid res-
idues in length.
The actual identification of the N-terminal acetyltrans-
ferases (NATs) came many years later. The yeast NatA
complex, a major NAT composed of the catalytic subunit
Naa10p (Ard1p) and the auxiliary subunit Naa15p
(Nat1p), was identified in 1989 by the joint efforts of
Sternglanz, Sherman, Grunstein and coworkers [8], and
further as a physical complex in 1992 by Park and Szostak
[9]. Then, Naa30p (Mak3p) [10] and Naa20p (Nat3p)
[11] were identified as additional NATs with specific sub-
strate specificities. In 1999, Sherman, Blomberg and cow-
orkers introduced the NAT type classification based on the
ability of the different NATs to acetylate different sub-
strates: NatA (Naa10p-Naa15p), NatB (Naa20p) and
NatC (Naa30p) [11]. Later, the auxiliary subunits of the
NatB (Naa25p/Mdm20p) and NatC (Naa35p/Mak10p
and Naa38p/Mak31p) complexes were identified by
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Polevoda and Sherman [12,13] and by Singer and Shaw
(NatB) [14]. In 2003, an additional enzyme was discov-
ered, Naa40p (Nat4p), making a new NAT type: NatD
[15]. The same year, Rospert and co-workers provided a
mechanistic insight of the NatA complex, revealing that
the Naa15p subunit anchors the NatA complex to the
ribosome and the nascent polypeptide, and that a poten-
tial fifth NAT, Naa50p (Nat5p), is physically associated
with Naa10p and Naa15p [16]. NATs from higher eukary-
otes have recently been identified [17,18] and between
2005 and 2009, all major human N-terminal acetyltrans-
ferases, NatA, NatB and NatC, were characterized [19-23].
Finally, large scale targeted proteomics has now made it
possible to quantitatively analyse protein N-terminal
acetylation on hundreds of unique proteins from a bio-
logical sample. Work by Arnesen and Van Damme et al.,
has revealed the conservation of substrate specificity of
the NatA complex from yeast to humans, and also pro-
vided more accurate determinations of N-terminal
acetylation patterns [24].
Despite some very good examples describing the impor-
tance of N-terminal acetylation at the substrate level
[10,13,14,25-29], the overall importance of N-terminal
acetylation remains unknown and represent an important
future challenge.
Furthermore, in higher eukaryotes there might be more
NATs to be discovered and there are several distinct sub-
strate types that are acetylated by so far unknown NATs.
Summary of the supplement
The NAT field has only had a few dedicated groups prima-
rily focusing on N-terminal acetylation and NATs, and
there is currently no scientific community specifically
focusing on this field, despite the fact that it is one of the
most common protein modifications, and knockout/
knockdown phenotypes of NATs suggest very important
functional aspects. In order to contribute to the promo-
tion and activation of this field, we have in 2007 and 2008
arranged two symposia in Bergen, Norway. This supple-
ment contains selected proceedings from some of the
symposia participants.
An issue of importance, and discussed at these meetings,
is the nomenclature of the NAT enzymes. For many rea-
sons, including significant confusion from the non spe-
cialist scientists, all participants agreed that a novel
nomenclature system for the NATs should be developed
by the Sherman lab. After a round of approval among sci-
entists in the field around the world, the new nomencla-
ture is presented here by Polevoda et al. [30].
The human NATs have recently been discovered and sev-
eral presentations from the group of Varhaug and Lille-
haug were made at the symposia. Here, Gromyko and
Starheim et al. have made a review of the human NATs,
composition and biological significance to summarize the
current knowledge of the human NATs both from their
own group, but also recent results from several other
research groups [31].
The next paper by Ametzazurra et al., describes the human
NatB, which along with two previous papers [22,32] iden-
tifies this human complex composed of the catalytic sub-
unit hNaa20p (hNat3) and the auxiliary subunit
hNaa25p (hMdm20). The importance of the hNatB com-
plex is stressed by the significant phenotypes associated
with its knockdown [19].
In order to study N-terminal acetylation, it is of vital
importance to have appropriate methodology available.
Evjenth et al. describes a reliable assay for the determina-
tion of in vitro N-terminal acetylation, including substrate
specificity and enzymatic parameters [33].
In the final paper, Van Damme et al. present a robust and
sensitive method for assessing the N-terminal acetylation
status of proteins in vivo [34]. The method is based on in
vitro modifications of the protein N-termini, Cofractional
Diagonal Chromatography (COFRADIC) [35] and finally
Mass Spectrometry analysis. The proof of principle was
very recently demonstrated in a large scale analysis of
more than 1000 unique yeast and human proteins [24].
Clearly, this and similar methodologies will be crucial for
the in depth studies that will be pursued in the next years.
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